Tag: GLP-1
-

Statins, Blood Sugar, and the Comparisons Medicine Still Owes Patients
A metabolic warning deserves rigorous follow-up. Patients also deserve direct evidence comparing the prevention strategies they can actually choose. by James Lyons-Weiler, Popular Rationalism, ©2026 (Nov. 14, 2026) — A 2024 atorvastatin study reported an awkward combination: improved cholesterol measurements accompanied worsening markers of glucose regulation. It points to a question that cardiovascular prevention must…
